Drug Shortage Report for APO-LEVOTHYROXINE
| Report ID | 257170 |
| Drug Identification Number | 02550806 |
| Brand name | APO-LEVOTHYROXINE |
| Common or Proper name | LEVOTHYROXINE |
| Company Name | APOTEX INC |
| Market Status | APPROVED |
| Active Ingredient(s) | LEVOTHYROXINE SODIUM |
| Strength(s) | 200MCG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 90 BTL |
| ATC code | H03AA |
| ATC description | THYROID PREPARATIONS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2023-11-18 |
| Estimated end date | |
| Actual end date | 2025-08-15 |
| Shortage status | Actual shortage |
| Updated date | 2025-08-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-08-07 | French | Compare |
| v1 | 2025-08-07 | English | Compare |
Showing 1 to 2 of 2